Institution
All India Institute of Medical Sciences Bhubaneswar
Also known as: AIIMS Bhubaneswar · Netaji Subhas Chandra Bose All India Institute of Medical Sciences
- 17running trials
- 4closed trials
- 7,090publications (OpenAlex)
Running trials
Not yet recruiting
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
NCT07861100· Phase 3· Novo Nordisk A/S· Source
Not yet recruiting
Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia
NCT07445620· All India Institute of Medical Sciences, Bhubaneswar· Source
Recruiting
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
NCT07797335· Phase 3· Novo Nordisk A/S· Source
Recruiting
A Clinical Trial to Improve Treatment Outcomes Among Persons With Drug Sensitive Pulmonary TB Treated With 4 or 6 Months of High Dose Rifampicin Containing Regimens With or Without Levofloxacin
NCT07947056· Phase 3· Tuberculosis Research Centre, India· Source
Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001· Phase 3· Novo Nordisk A/S· Source
Recruiting
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571109· Phase 3· Novo Nordisk A/S· Source
Recruiting
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571005· Phase 3· Novo Nordisk A/S· Source
Recruiting
Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus
NCT07131813· Phase 4· All India Institute of Medical Sciences, Bhubaneswar· Source
Recruiting
Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India
NCT07044687· Phase 4· AbbVie· Source
Active, not recruiting
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)
NCT06726265· Phase 3· Immutep S.A.S.· Source
Recruiting
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
NCT06676384· Phase 4· Christian Medical College, Vellore, India· Source
Recruiting
Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma
NCT06755450· Phase 1· Aurigene Discovery Technologies Limited· Source
Active, not recruiting
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824· Phase 3· Boehringer Ingelheim· Source
Active, not recruiting
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
NCT06200207· Phase 3· Novo Nordisk A/S· Source
Recruiting
PET/CT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS
NCT06923098· All India Institute of Medical Sciences, Bhubaneswar· Source
Recruiting
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
NCT05431088· Phase 2/3· Pfizer· Source
Active, not recruiting
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
NCT05152147· Phase 3· Jazz Pharmaceuticals· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Registry name variants (5)
Show allHide
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
All India Institute of Medical Sciences (AIIMS) - Bhubaneswar
Bhubaneswar, 751019
8 trials
AIIMS, Bhubaneswar
Bhubaneswar, Odisha 751019
7 trials
All India Institute of Medical Sciences, Bhubaneswar
Bhubaneswar, Odisha 751019
4 trials
All India Institute Of Medical Sciences - Bhubaneswar
Bhubaneswar, Odisha 751019
1 trial
Department of ENT-Head and Neck Surgery, All India Institute of Medical Sciences, Bhubaneswar
Bhubaneswar
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
Report an error